NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 23, 2020 Bullish $6.81 X 0
Yanko Kuraica Yanko Kuraica @YankoKuraica.135559
Jan 23, 2020 Bullish $6.81 X 0
2poJeff 2poJeff Pro
Jan 23, 2020 $7.15 +4.99% $6.81 X 95.01% 0
2poJeff 2poJeff Pro
Dec 4, 2019 $7.18 +0.98% $7.11 X 99.02% 1
esteban sanchez esteban sanchez @estebansanchez.128275
Dec 4, 2019 Bearish $7.11 X 1
Mike Keady Mike Keady @MikeKeady.129199
Dec 4, 2019 $7.12 +0.14% $7.11 X 99.86% 6
Nov 4, 2019 $6.69 +1.98% $6.56 X 98.02% 1
JS JS Pro
Nov 4, 2019 $6.80 +3.66% $6.56 X 96.34% 0
travis hensley travis hensley @travishensley.125661
Nov 4, 2019 $14.00 +113.41% Unrealistic Excluded from avg $6.56 X 0.00% 0
@.112521
Jun 3, 2019 $9.00 +17.34% $7.67 X 82.66% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE